{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:59:12Z","timestamp":1778857152145,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clinbiochem.2012.09.012","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T09:01:06Z","timestamp":1348390866000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Complement and atherosclerosis\u2014united to the point of no return?"],"prefix":"10.1016","volume":"46","author":[{"given":"Michael","family":"Torzewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucharit","family":"Bhakdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0005","first-page":"496","article-title":"Plasma protein insudation as an index of early coronary atherogenesis","volume":"143","author":"Zhang","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.ATV.1.1.38","article-title":"Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx","volume":"1","author":"Stender","year":"1981","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024919-0.50007-2","article-title":"The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis","volume":"19","author":"Camejo","year":"1982","journal-title":"Adv Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00041433-199810000-00012","article-title":"The response-to-retention hypothesis of atherogenesis reinforced","volume":"9","author":"Williams","year":"1998","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Skalen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1515\/CCLM.2006.259","article-title":"Initiation and progression of atherosclerosis\u2014enzymatic or oxidative modification of low-density lipoprotein?","volume":"44","author":"Torzewski","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0040","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0045","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI119813","article-title":"Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions","volume":"100","author":"Napoli","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0050","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.ATV.18.6.884","article-title":"An animal model to study local oxidation of LDL and its biological effects in the arterial wall","volume":"18","author":"Calara","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0055","first-page":"201","article-title":"Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-o-negative particles","volume":"114","author":"Kruth","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0021-9150(85)90045-0","article-title":"Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development","volume":"57","author":"Kruth","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0065","first-page":"109","article-title":"Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit","volume":"123","author":"Simionescu","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0070","first-page":"73","article-title":"Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas","volume":"131","author":"Chao","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1160\/TH03-12-0733","article-title":"Beyond cholesterol: the enigma of atherosclerosis revisited","volume":"91","author":"Bhakdi","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0080","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1073\/pnas.0503202102","article-title":"Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice","volume":"102","author":"Hirschfield","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0085","doi-asserted-by":"crossref","first-page":"13768","DOI":"10.1073\/pnas.0706027104","article-title":"Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia","volume":"104","author":"Kovacs","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Paul","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0095","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1161\/01.ATV.0000171983.95612.90","article-title":"Role of C-reactive protein in atherogenesis: can the apolipoprotein e knockout mouse provide the answer?","volume":"25","author":"Reifenberg","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.thromres.2008.06.017","article-title":"Endotoxin accelerates atherosclerosis independent of complement activation","volume":"123","author":"Reifenberg","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2007.05.010","article-title":"Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in ApoE\u2212\/\u2212 mice","volume":"196","author":"Tennent","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1160\/TH07-10-0595","article-title":"No effect of C-reactive protein on early atherosclerosis in ldlr\u2212\/\u2212\/human C-reactive protein transgenic mice","volume":"99","author":"Torzewski","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0115","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/01.ATV.0000171992.36710.1e","article-title":"No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden\/human C-reactive protein transgenic mice","volume":"25","author":"Trion","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2009.01.038","article-title":"Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis","volume":"206","author":"Torzewski","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.cdd.4401633","article-title":"Fatty acids liberated from low-density lipoprotein trigger endothelial apoptosis via mitogen-activated protein kinases","volume":"12","author":"Dersch","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2009.04.004","article-title":"Hypersusceptibility of neutrophil granulocytes towards lethal action of free fatty acids contained in enzyme-modified atherogenic low density lipoprotein","volume":"207","author":"Lux","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0135","doi-asserted-by":"crossref","first-page":"26931","DOI":"10.1074\/jbc.M111.243485","article-title":"Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity","volume":"286","author":"Reiss","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1160\/TH07-12-0737","article-title":"Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity","volume":"100","author":"Schwarz","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.ATV.18.3.369","article-title":"Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0150","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.182.6.1959","article-title":"On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety","volume":"182","author":"Bhakdi","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0155","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.ATV.21.6.1004","article-title":"Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class b scavenger-receptor CD36","volume":"21","author":"Kapinsky","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0160","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1074\/jbc.274.11.7495","article-title":"Apolipoprotein b stimulates formation of monocyte-macrophage surface-connected compartments and mediates uptake of low density lipoprotein-derived liposomes into these compartments","volume":"274","author":"Kruth","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.172.2.547","article-title":"Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions","volume":"172","author":"Seifert","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0170","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/01.ATV.0000144016.85221.66","article-title":"Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis","volume":"24","author":"Torzewski","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0175","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nri2415","article-title":"The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models","volume":"8","author":"Weber","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(85)90030-9","article-title":"Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque","volume":"57","author":"Vlaicu","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0185","first-page":"477","article-title":"Quantitative evaluation of the terminal C5b-9 complement complex by elisa in human atherosclerotic arteries","volume":"69","author":"Niculescu","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0190","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.ATV.17.11.2448","article-title":"Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions","volume":"17","author":"Torzewski","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.ATV.16.5.673","article-title":"Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation","volume":"16","author":"Torzewski","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0200","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/01.ATV.18.11.1790","article-title":"Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits","volume":"18","author":"Schmiedt","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0205","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.molimm.2009.02.009","article-title":"CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice","volume":"46","author":"An","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0210","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex","volume":"104","author":"Wu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0215","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2011.06.015","article-title":"CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism","volume":"179","author":"Lewis","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0220","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2353\/ajpath.2007.060406","article-title":"Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"170","author":"Bhatia","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0225","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","article-title":"C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity","volume":"192","author":"Gershov","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0230","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4049\/jimmunol.136.4.1354","article-title":"Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis","volume":"136","author":"Berman","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","article-title":"Regulation of complement activation by C-reactive protein","volume":"42","author":"Mold","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2006.06.013","article-title":"Complement regulation in human atherosclerotic coronary lesions. Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway","volume":"192","author":"Oksjoki","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0245","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1021\/bi9021022","article-title":"Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase","volume":"49","author":"Biro","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0250","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1161\/01.CIR.0000038366.11851.D0","article-title":"Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: Role of free fatty acids","volume":"106","author":"Suriyaphol","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0255","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (felic) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0260","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0265","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/01.CIR.0000124228.08972.26","article-title":"Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence","volume":"109","author":"Bhakdi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1373\/clinchem.2011.165787","article-title":"Biomarkers in cardiovascular clinical trials: past, present, future","volume":"58","author":"Halim","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0275","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.ATV.18.9.1376","article-title":"Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages","volume":"18","author":"Klouche","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0280","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.105.611350","article-title":"Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out","volume":"113","author":"Scirica","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0285","first-page":"2135","article-title":"Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis","volume":"113","author":"Verma","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0290","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0295","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0300","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1365-2362.1999.00548.x","article-title":"Complement activation by oxidatively modified low-density lipoproteins","volume":"29","author":"Wieland","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000332435","article-title":"The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues","volume":"4","author":"Francescut","year":"2012","journal-title":"J Innate Immun"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2353\/ajpath.2008.070154","article-title":"Exaggerated neointima formation in human c-reactive protein transgenic mice is igG Fc receptor type I (Fc-gamma ri)-dependent","volume":"172","author":"Xing","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/278259a0","article-title":"Serum amyloid p-component is an acute-phase reactant in the mouse","volume":"278","author":"Pepys","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0320","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/CIRCULATIONAHA.109.872796","article-title":"Human C-reactive protein does not promote atherosclerosis in transgenic rabbits","volume":"120","author":"Koike","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0325","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/hc3401.093153","article-title":"Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet","volume":"104","author":"Lehr","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0330","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.110.981365","article-title":"The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"122","author":"Malik","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.09.012_bb0335","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.CIR.99.8.993","article-title":"Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages","volume":"99","author":"Xu","year":"1999","journal-title":"Circulation"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:08:39Z","timestamp":1762114119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012005425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":67,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0009912012005425"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.012","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement and atherosclerosis\u2014united to the point of no return?","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}